THE Australian Medicinal Cannabis Association (AMCA) and Medicinal Cannabis Industry Australia (MCIA) have called for cross-sector collaboration among healthcare stakeholders as public submissions to the Therapeutic Goods Administration (TGA) consultation on the safety and regulatory oversight of unapproved medicinal cannabis products close.

“Reform must be guided by science, patient experience and a shared commitment to quality and safety,” said Teresa Nicoletti, Chair of AMCA.

The post Call for cannabis collaboration appeared first on Pharmacy Daily.